OTCMKTS:MEDD

Medical Imaging Competitors

$0.0078
+0.00 (+21.88 %)
(As of 04/9/2021 10:07 PM ET)
Add
Compare
Today's Range
$0.01
Now: $0.01
$0.01
50-Day Range
$0.01
MA: $0.01
$0.02
52-Week Range
$0.00
Now: $0.01
$0.03
Volume100 shs
Average Volume165,212 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Medical Imaging (OTCMKTS:MEDD) Vs. OLK, OCDX, BDSX, LHDX, AKU, and NOTV

Should you be buying MEDD stock or one of its competitors? Companies in the industry of "diagnostics & research" are considered alternatives and competitors to Medical Imaging, including Olink Holding AB (publ) (OLK), Ortho Clinical Diagnostics (OCDX), Biodesix (BDSX), Lucira Health (LHDX), Akumin (AKU), and Inotiv (NOTV).

Medical Imaging (OTCMKTS:MEDD) and Olink Holding AB (publ) (NASDAQ:OLK) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership.

Earnings & Valuation

This table compares Medical Imaging and Olink Holding AB (publ)'s revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medical ImagingN/AN/AN/AN/AN/A
Olink Holding AB (publ)N/AN/AN/AN/AN/A

Profitability

This table compares Medical Imaging and Olink Holding AB (publ)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medical ImagingN/AN/AN/A
Olink Holding AB (publ)N/AN/AN/A

Analyst Ratings

This is a summary of current ratings and target prices for Medical Imaging and Olink Holding AB (publ), as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medical Imaging0000N/A
Olink Holding AB (publ)0000N/A

Ortho Clinical Diagnostics (NASDAQ:OCDX) and Medical Imaging (OTCMKTS:MEDD) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, profitability, earnings, institutional ownership and risk.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Ortho Clinical Diagnostics and Medical Imaging, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ortho Clinical Diagnostics011102.92
Medical Imaging0000N/A

Ortho Clinical Diagnostics presently has a consensus price target of $24.2727, indicating a potential upside of 25.12%. Given Ortho Clinical Diagnostics' higher probable upside, equities research analysts clearly believe Ortho Clinical Diagnostics is more favorable than Medical Imaging.

Profitability

This table compares Ortho Clinical Diagnostics and Medical Imaging's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ortho Clinical DiagnosticsN/AN/AN/A
Medical ImagingN/AN/AN/A

Valuation & Earnings

This table compares Ortho Clinical Diagnostics and Medical Imaging's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ortho Clinical DiagnosticsN/AN/AN/AN/AN/A
Medical ImagingN/AN/AN/AN/AN/A

Summary

Ortho Clinical Diagnostics beats Medical Imaging on 2 of the 2 factors compared between the two stocks.

Medical Imaging (OTCMKTS:MEDD) and Biodesix (NASDAQ:BDSX) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, dividends, institutional ownership, valuation and risk.

Analyst Recommendations

This is a breakdown of current ratings for Medical Imaging and Biodesix, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medical Imaging0000N/A
Biodesix00403.00

Biodesix has a consensus target price of $26.00, indicating a potential upside of 36.48%. Given Biodesix's higher probable upside, analysts plainly believe Biodesix is more favorable than Medical Imaging.

Profitability

This table compares Medical Imaging and Biodesix's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medical ImagingN/AN/AN/A
BiodesixN/AN/AN/A

Valuation & Earnings

This table compares Medical Imaging and Biodesix's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medical ImagingN/AN/AN/AN/AN/A
BiodesixN/AN/AN/AN/AN/A

Summary

Biodesix beats Medical Imaging on 2 of the 2 factors compared between the two stocks.

Medical Imaging (OTCMKTS:MEDD) and Lucira Health (NASDAQ:LHDX) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, dividends, institutional ownership, valuation and risk.

Analyst Recommendations

This is a breakdown of current ratings for Medical Imaging and Lucira Health, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medical Imaging0000N/A
Lucira Health01202.67

Lucira Health has a consensus target price of $22.00, indicating a potential upside of 132.56%. Given Lucira Health's higher probable upside, analysts plainly believe Lucira Health is more favorable than Medical Imaging.

Profitability

This table compares Medical Imaging and Lucira Health's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medical ImagingN/AN/AN/A
Lucira HealthN/AN/AN/A

Valuation & Earnings

This table compares Medical Imaging and Lucira Health's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medical ImagingN/AN/AN/AN/AN/A
Lucira HealthN/AN/AN/AN/AN/A

Summary

Lucira Health beats Medical Imaging on 2 of the 2 factors compared between the two stocks.

Medical Imaging (OTCMKTS:MEDD) and Akumin (NASDAQ:AKU) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership and dividends.

Profitability

This table compares Medical Imaging and Akumin's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medical ImagingN/AN/AN/A
AkuminN/AN/AN/A

Valuation and Earnings

This table compares Medical Imaging and Akumin's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medical ImagingN/AN/AN/AN/AN/A
AkuminN/AN/AN/AN/AN/A

Insider and Institutional Ownership

30.4% of Akumin shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Analyst Ratings

This is a summary of current recommendations and price targets for Medical Imaging and Akumin, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medical Imaging0000N/A
Akumin00103.00

Summary

Akumin beats Medical Imaging on 2 of the 2 factors compared between the two stocks.

Inotiv (NASDAQ:NOTV) and Medical Imaging (OTCMKTS:MEDD) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Inotiv and Medical Imaging, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Inotiv0000N/A
Medical Imaging0000N/A

Earnings and Valuation

This table compares Inotiv and Medical Imaging's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
InotivN/AN/AN/AN/AN/A
Medical ImagingN/AN/AN/AN/AN/A

Profitability

This table compares Inotiv and Medical Imaging's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
InotivN/AN/AN/A
Medical ImagingN/AN/AN/A


Medical Imaging Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
OLK
Olink Holding AB (publ)
0.0$37.04+1.5%$4.47 billionN/A0.00
Ortho Clinical Diagnostics logo
OCDX
Ortho Clinical Diagnostics
1.8$19.40+0.0%$4.32 billionN/A0.00
Biodesix logo
BDSX
Biodesix
1.6$19.05+0.5%$503.65 millionN/A0.00
Lucira Health logo
LHDX
Lucira Health
1.6$9.43+8.9%$331.02 millionN/A0.00News Coverage
Akumin logo
AKU
Akumin
0.6$3.27+0.6%$228.09 millionN/A0.00
NOTV
Inotiv
0.0$19.54+1.8%$221.51 millionN/A0.00
Relay Medical logo
RYMDF
Relay Medical
0.0$0.46+3.6%$69.29 millionN/A0.00
Global WholeHealth Partners logo
GWHP
Global WholeHealth Partners
0.0$0.73+0.6%$49.60 millionN/A0.00
Epigenomics logo
EPGNY
Epigenomics
0.6$13.77+1.2%$0.00N/A0.00
ETAH
Eternity Healthcare
0.6$0.00+36.4%$0.00N/A0.00Gap Up
PRLX
Parallax Health Sciences
0.5$0.02+0.0%$0.00N/A0.00Gap Up
Siemens Healthineers logo
SMMNY
Siemens Healthineers
0.5$28.08+0.4%$0.00N/A0.00
WUXIF
WuXi AppTec
1.0$18.50+5.4%$0.00N/A0.00Gap Down
This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.